Clinical study assessing antibody adding (panitumumab) to a chemotherapy of reference in metastatic colorectal cancer (FOLFOX), following a strategy with a switch between full treatment and light treatment.
收藏NIAID Data Ecosystem2026-03-11 收录
下载链接：
https://www.omicsdi.org/dataset/ecrin-mdr-crc/2536894
下载链接
链接失效反馈官方服务：
资源简介：
Primary objectives: The primary objective is to evaluate the disease control duration
Primary endpoints: the primary endpoint is the disease control duration
创建时间：
2019-08-15
